Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study
Annemarie B. van der Aart-van der Beek PharmD, Ellen Apperloo MD, Niels Jongs PhD, Dennis B. Rouw MD, C. David Sjöström MD, Iris Friedli PhD, Lars Johansson PhD, Daniël H. van Raalte… Weiterlesen »Albuminuria-lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross-over clinical study